Walter J. Loos

6.8k total citations
135 papers, 5.6k citations indexed

About

Walter J. Loos is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Walter J. Loos has authored 135 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Oncology, 72 papers in Molecular Biology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Walter J. Loos's work include Cancer therapeutics and mechanisms (62 papers), Cancer Treatment and Pharmacology (40 papers) and Neutropenia and Cancer Infections (33 papers). Walter J. Loos is often cited by papers focused on Cancer therapeutics and mechanisms (62 papers), Cancer Treatment and Pharmacology (40 papers) and Neutropenia and Cancer Infections (33 papers). Walter J. Loos collaborates with scholars based in Netherlands, United States and Sweden. Walter J. Loos's co-authors include Jaap Verweij, Alex Sparreboom, Ron H.J. Mathijssen, Peter de Bruijn, Kees Nooter, G. Stoter, Albert J. ten Tije, Erik A.C. Wiemer, Hans Gelderblom and André Planting and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Walter J. Loos

135 papers receiving 5.4k citations

Peers

Countries citing papers authored by Walter J. Loos

Since Specialization

Citations

This map shows the geographic impact of Walter J. Loos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter J. Loos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter J. Loos more than expected).

Fields of papers citing papers by Walter J. Loos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter J. Loos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter J. Loos. The network helps show where Walter J. Loos may publish in the future.

Co-authorship network of co-authors of Walter J. Loos

This figure shows the co-authorship network connecting the top 25 collaborators of Walter J. Loos. A scholar is included among the top collaborators of Walter J. Loos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter J. Loos. Walter J. Loos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Toward Prediction of Efficacy of Chemotherapy: A Proof of Concept Study in Lung Cancer Patients Using [11C]docetaxel and Positron Emission Tomography 2013 ·Clinical Cancer Research ·Astrid A.M. van der Veldt, Mark Lubberink, Ron H.J. Mathijssen, Walter J. Loos, Gerarda J.M. Herder, Henri N. Greuter, Emile F.I. Comans, (unknown), Jonas Eriksson, Albert D. Windhorst, N. Harry Hendrikse, Pieter E. Postmus, Egbert F. Smit, Adriaan A. Lammertsma	60
2	Influence of Polymorphic OATP1B-Type Carriers on the Disposition of Docetaxel 2012 ·Clinical Cancer Research ·Anne‐Joy M. de Graan, Cynthia S. Lancaster, Amanda Obaidat, Bruno Hagenbuch, Laure Elens, Lena E. Friberg, Peter de Bruijn, Shuiying Hu, Alice A. Gibson, Gitte Hoffmann Bruun, Thomas J. Corydon, Torben Stamm Mikkelsen, Aisha L. Walker, Guoqing Du, Walter J. Loos, Ron H. N. van Schaik, Sharyn D. Baker, Ron H.J. Mathijssen, Alex Sparreboom	76
3	Influence of Smoking on the Pharmacokinetics and Toxicity Profiles of Taxane Therapy 2012 ·Clinical Cancer Research ·Anne‐Joy M. de Graan, Walter J. Loos, Lena E. Friberg, Sharyn D. Baker, Jessica M. van der Bol, Leni van Doorn, Erik A.C. Wiemer, Bronno van der Holt, Jaap Verweij, Ron H.J. Mathijssen	29
4	A Long-term Prospective Population Pharmacokinetic Study on Imatinib Plasma Concentrations in GIST Patients 2012 ·Clinical Cancer Research ·Karel Eechoute, Martin N. Fransson, (unknown), Floris A. de Jong, Alex Sparreboom, Winette T.A. van der Graaf, Lena E. Friberg, Gaia Schiavon, Erik A.C. Wiemer, Jaap Verweij, Walter J. Loos, Ron H.J. Mathijssen, Ugo De Giorgi	87
5	Drug transporters of platinum-based anticancer agents and their clinical significance 2011 ·Drug Resistance Updates ·Herman Burger, Walter J. Loos, Karel Eechoute, Jaap Verweij, Ron H.J. Mathijssen, Erik A.C. Wiemer	194
6	A CYP3A4 Phenotype–Based Dosing Algorithm for Individualized Treatment of Irinotecan 2010 ·Clinical Cancer Research ·Jessica M. van der Bol, Ron H.J. Mathijssen, Geert-Jan Creemers, André Planting, Walter J. Loos, Erik A.C. Wiemer, Lena E. Friberg, Jaap Verweij, Alex Sparreboom, Floris A. de Jong	50
7	Cisplatin-Induced Downregulation of OCTN2 Affects Carnitine Wasting 2010 ·Clinical Cancer Research ·Cynthia S. Lancaster, Chaoxin Hu, Ryan M. Franke, Kelly K. Filipski, Shelley Orwick, Zhaoyuan Chen, Zhili Zuo, Walter J. Loos, Alex Sparreboom	43
8	Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies 2010 ·British Journal of Cancer ·Paul Hamberg, Neeltje Steeghs, Walter J. Loos, (unknown), (unknown), Metin Tascilar, Jaco J. Verweij, Hans Gelderblom, Stefan Sleijfer	16
9	Effects of methimazole on the elimination of irinotecan 2010 ·Cancer Chemotherapy and Pharmacology ·Jessica M. van der Bol, Theo J. Visser, Walter J. Loos, Floris A. de Jong, Erik A.C. Wiemer, Maarten O. van Aken, André Planting, Jan H.M. Schellens, Jaap Verweij, Ron H.J. Mathijssen	6
10	Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: a Phase I Study 2009 ·Clinical Cancer Research ·Constantijne H. Mom, Jaap Verweij, Corina N.A.M. Oldenhuis, Jourik A. Gietema, Norma Lynn Fox, R. Miceli, Ferry A.L.M. Eskens, Walter J. Loos, Elisabeth G.E. de Vries, Stefan Sleijfer	85
11	Influence of ketoconazole on the fecal and urinary disposition of docetaxel 2007 ·Cancer Chemotherapy and Pharmacology ·Frederike K. Engels, Walter J. Loos, Ron A. A. Mathôt, Ron H. N. van Schaik, Jaap Verweij	7
12	Influence of medicinal cannabis (MC) on the pharmacokinetics (PK) of docetaxel (DOC) and irinotecan (CPT-11) 2005 ·Cancer Research ·Floris A. de Jong, (unknown), Alex Sparreboom, Walter J. Loos, Peter de Bruijn, Lena E. Friberg, Ron A. A. Mathôt, Jaap Verweij, Ron H.J. Mathijssen	5
13	Comparative in vitro properties and clinical pharmacokinetics of paclitaxel following the administration of Taxol® and Paxene® 2005 ·Cancer Biology & Therapy ·Charity D. Scripture, János Szebeni, Walter J. Loos, William D. Figg, Alex Sparreboom	11
14	Indirect determination of the irinotecan metabolite 7-ethyl-10-O-glucuronyl-camptothecin in human samples 2004 ·Analytical Biochemistry ·Peter de Bruijn, Edwin W Willems, Walter J. Loos, Jaap Verweij, Alex Sparreboom	15
15	Red blood cells: a neglected compartment in topotecan pharmacokinetic analysis 2003 ·Anti-Cancer Drugs ·Walter J. Loos, Hans Gelderblom, Jaap Verweij, (unknown), Kees Nooter, G. Stoter, Alex Sparreboom	12
16	Role of erythrocytes and serum proteins in the kinetic profile of total 9-amino-20(S)-camptothecin in humans 1999 ·Anti-Cancer Drugs ·Walter J. Loos, Jaap Verweij, Hans Gelderblom, Maja J. De Jonge, Eric Brouwer, B.K. Dallaire, Alex Sparreboom	32
17	Determination of 5-fluorouracil in microvolumes of human plasma by solvent extraction and high-performance liquid chromatography 1999 ·Journal of Chromatography B Biomedical Sciences and Applications ·Walter J. Loos, Peter de Bruijn, Lia van Zuylen, Jaap Verweij, Kees Nooter, G. Stoter, Alex Sparreboom	28
18	Liquid chromatographic determination of irinotecan and three major metabolites in human plasma, urine and feces 1998 ·Journal of Chromatography B Biomedical Sciences and Applications ·Alex Sparreboom, Peter de Bruijn, Maja J.A. de Jonge, Walter J. Loos, Gerrit Stoter, Jaap Verweij, Kees Nooter	72
19	蛍光検出逆相高速液体クロマトグラフィーによるヒト血しょう中イリノテカン(CPT‐11)とその活性代謝産物SN‐38の定量 1997 ·Journal of Chromatography B ·(unknown), Jaco J. Verweij, Walter J. Loos, Kees Nooter, G. Stoter, Alex Sparreboom	20
20	Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors. 1997 ·Journal of Clinical Oncology ·G.J. Creemers, C J Gerrits, John R. Eckardt, Jan H.M. Schellens, Howard A. Burris, André Planting, G I Rodriguez, Walter J. Loos, I Hudson, Colin Broom, Jaap Verweij, Daniel D. Von Hoff	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact